Keyur Patel, DO
Undersea and Hyperbaric Medicine · North Port, FLNPI 1326340555
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $995 of the $1,126 with a category attached, or 88.4%. 18 manufacturers reported payments, led by Smith+Nephew at 25.4% of the total.
Across 40 payments — averaging $28.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$286
- Sanofi$137
- Intuitive Surgical$135
- Tactile Systems Technology Inc$118
- Paratek Pharmaceuticals, Inc.$83
- Hartmann USA, Inc.$53
- plus $314 from 12 others
Across 7 payments — averaging $13,664 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Convatec Inc.$96K
What the payments were for
- Food & beverage$99588%
- Education$13012%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 15 | $286 |
| Sanofi | 2 | $137 |
| Intuitive Surgical | 1 | $135 |
| Tactile Systems Technology Inc | 1 | $118 |
| Paratek Pharmaceuticals, Inc. | 5 | $83 |
| Hartmann USA, Inc. | 3 | $53 |
| Molnlycke Health Care US, LLC | 1 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| UCB, Inc. | 1 | $33 |
| Osiris Therapeutics Inc. | 1 | $31 |
| Sobi, Inc | 1 | $25 |
| Kerecis Limited | 1 | $24 |
| Misonix Inc | 1 | $23 |
| Organogenesis Inc. | 1 | $23 |
| Octapharma USA, Inc. | 1 | $22 |
| Next Science LLC | 1 | $17 |
| Mimedx Group, Inc. | 1 | $15 |
| Cashflow Solutions, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$235
- Da Vinci Surgical System$135
- FLEXITOUCH$118
- ACTITOUCH$118
- ENTRE$118
How this compares
$1,126 in reported general payments places this provider in the 55th percentile of 32 undersea and hyperbaric medicine providers in Florida.
See all undersea and hyperbaric medicine providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 21 | $6,493 |
| SantylCollagenase Clostridium Hist. | 21 | $6,164 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 34 | $507 |
| Mupirocin | 66 | $463 |
| Doxycycline Hyclate | 27 | $402 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 18 | $371 |
| Levofloxacin | 30 | $267 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 20 | $83 |
| Oxycodone Hcl | 18 | $64 |
| Tramadol Hcl | 13 | $47 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $286 | $6,16421 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 32 undersea and hyperbaric medicine providers in Florida.
Other undersea and hyperbaric medicine in North Port
- Stephen PappachenLakeland$1.3M
- Juan BravoLakeland$6K
- Magaly RodriguezTampa$6K
- Lawrence BachlePunta Gorda$4K
- Edgar RhodesJacksonville$3K
- Walter ConlanOrlando$3K
- Paolina PantchevaKissimmee$2K
- Paul JohnsonDaytona Beach$2K
- Blane ShatkinPembroke Pines$2K
- Reynald AllamClearwater$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.